Wanjia Group Holdings Limited (HKG:0401)
Hong Kong · Delayed Price · Currency is HKD 0.1300
0.00 (0.00%)
Aug 20, 2026, 4:09 PM HKT
Wanjia Group Holdings Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 165.39 | 165.39 | 161.69 | 181.09 | 173.7 | 154.82 |
Revenue Growth | 1.03% | 2.28% | -10.71% | 4.25% | 12.19% | 35.71% |
Gross Profit Gross Profit Growth | 44.43 | 44.43 | 50.35 | 54.74 | 56.94 | 54.23 |
Operating Income Operating Income Growth | -5.17 | -5.17 | -3.96 | -14.27 | 0.02 | -1.61 |
Net Income Net Income Growth | -9.86 | -9.86 | -6.62 | -39.98 | 1.82 | -51 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.07 | 0.00 | -0.09 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Hemodialysis Treatment and Consultancy Service Business Hemodialysis Treatment and Consultancy Service Business Growth | 110.06 | 110.06 | 111.2 | 129.56 | 121.42 | 103.64 |
Pharmaceutical Wholesale and Distribution Business Pharmaceutical Wholesale and Distribution Business Growth | 55.32 | 55.32 | 50.49 | 51.54 | 52.28 | 51.18 |
Total Total Growth | 165.39 | 165.39 | 161.69 | 181.09 | 173.7 | 154.82 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 33.03 | 33.03 | 24.08 | 18.23 | 9.88 | 5.77 |
Total Debt Total Debt Growth | 20.76 | 20.76 | 21.72 | 15.6 | 25.17 | 24.49 |
Net Cash (Debt) Net Cash Growth | 12.27 | 12.27 | 2.36 | 2.63 | -15.29 | -18.72 |
Net Cash Growth | 49.59% | 420.18% | -10.24% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.02 | 0.02 | 0.00 | 0.00 | -0.03 | -0.03 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -7.19 | -7.19 | 10.65 | 9.3 | 9.39 | 2.12 |
Capital Expenditures CapEx Growth | -1.5 | -1.5 | -0.73 | -3.41 | -3.91 | -6.98 |
Free Cash Flow Free Cash Flow Growth | -8.69 | -8.69 | 9.92 | 5.89 | 5.47 | -4.86 |
Free Cash Flow Growth | - | - | 68.34% | 7.71% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 26.86% | 26.86% | 31.14% | 30.23% | 32.78% | 35.03% |
Operating Margin | -3.13% | -3.13% | -2.45% | -7.88% | 0.01% | -1.04% |
Pretax Margin | -5.37% | -5.37% | -3.40% | -22.72% | 1.41% | -31.45% |
Profit Margin | -5.96% | -5.96% | -4.09% | -22.08% | 1.05% | -32.94% |
FCF Margin | -5.25% | -5.25% | 6.13% | 3.25% | 3.15% | -3.14% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 55.41 | - |
P/FCF Ratio | - | - | 4.74 | 5.99 | 18.43 | - |
PS Ratio | 0.89 | 0.43 | 0.29 | 0.20 | 0.58 | 0.54 |